IsoRay, Inc. (NYSE MKT:ISR) Q4 2020 Earnings Conference Call - Final Transcript

[Operator Instructions] We'll take our first question from Ed Woo with Ascendiant Capital. Thank you, sir. Please go ahead.

Yeah, congratulations on the quarter and annual results. My question is -- has to physicians that you've been interacting with making sales calls. Have they said that -- things are pretty much back on track or there is still significant delays from the pandemic?

Hi Ed Woo. And thank you for your question today. We are communicating a lot with our physicians currently and what we're seeing is that -- certainly, the biggest impacts to date, we experienced was at the end of March and into April, and after that both our numbers as well as our physicians saw an increase back trending -- back towards normal patterns. We have seen a little bit of fluctuation in that, just based on some of the public health concerns and that's had kind of near-term effect on patient volumes from one market to another. But by and large, we're seeing the trend heading in the right direction.

Great. And then my next question is, trade shows were such a big part of your marketing program. Now that, it doesn't seem to be happening anytime soon. Have you been able to your outreach and marketing?

That's a really great question. So yes, trade shows are and professional society meetings really haven't been happening and probably won't happen this fall, as well. What we have found to be very effective, I think like a lot of other people, is working with Zoom and Microsoft teams and other platforms to communicate directly with our customers and our sales team has done some training on that and has really found that has been in the effective way to continue and reach out and talk to our customers. It certainly isn't the same as being with them face-to-face. But as things have eased up over the summer, our sales force back in the field. We continue to ask them to be very careful for themselves as well as follow all the rules in the institutions that they're visiting. But we are seeing more, more opening up of that type of activity as well.

Great, well thank you and wish you guys, good luck.

Thank you, Ed.

[Operator Instructions] We'll take our next question from RK Ramakanth. Please go ahead.

Thank you. Good evening, Lori, and congratulations on a very, very good year. Blu Build -- is expected to be the driver of growth, as you just stated in your opening remarks. So, in terms of In terms of trying to maintain that. How confident are you about your manufacturers ability not to be overrun by the requirements of COVID-19. And also to maintain the inventory that you need for keeping up the sales, because it looks like the sales are growing pretty good, as well?

Absolutely. So our our Blu Build manufacturer is back to manufacturing medical devices and we expect no interruptions, nor concerns in terms of capacity